148 related articles for article (PubMed ID: 24693896)
1. Autophagy, p53, and pancreatic cancer.
Iacobuzio-Donahue CA; Herman JM
N Engl J Med; 2014 Apr; 370(14):1352-3. PubMed ID: 24693896
[No Abstract] [Full Text] [Related]
2. The littlest patient.
Couzin-Frankel J
Science; 2014 Oct; 346(6205):24-7. PubMed ID: 25278593
[No Abstract] [Full Text] [Related]
3. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
Reicher S; Boyar FZ; Albitar M; Sulcova V; Agersborg S; Nga V; Zhou Y; Li G; Venegas R; French SW; Chung DS; Stabile BE; Eysselein VE; Anguiano A
Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950
[TBL] [Abstract][Full Text] [Related]
5. Early detection tools for pancreatic cancer.
Schmidt C
J Natl Cancer Inst; 2012 Aug; 104(15):1117-8. PubMed ID: 22851273
[No Abstract] [Full Text] [Related]
6. Translational research in pancreatic cancer: KRAS and beyond.
Boeck S; Ormanns S; Haas M; Bächmann S; Laubender RP; Siveke JT; Jung A; Kirchner T; Heinemann V
Pancreas; 2014 Jan; 43(1):150-2. PubMed ID: 24326376
[No Abstract] [Full Text] [Related]
7. [Genetic aspects of pancreatic cancer].
Grigor'eva IN; Efimova OV; Suvorova TS; Tov NL
Eksp Klin Gastroenterol; 2014; (10):70-6. PubMed ID: 25911935
[TBL] [Abstract][Full Text] [Related]
8. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells.
Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y
Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191
[TBL] [Abstract][Full Text] [Related]
9. Optimizing methods for the diagnosis of pancreatic cancer.
Brugge WR
J Clin Gastroenterol; 2007; 41(10):869-70. PubMed ID: 18090153
[No Abstract] [Full Text] [Related]
10. The KRAS-PDEδ interaction is a therapeutic target.
Cancer Discov; 2013 Jul; 3(7):OF20. PubMed ID: 23847364
[TBL] [Abstract][Full Text] [Related]
11. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
[TBL] [Abstract][Full Text] [Related]
12. Induction of Autophagic Cell Death in Apoptosis-resistant Pancreatic Cancer Cells using Benzo[α]phenoxazines Derivatives, 10-methyl-benzo[α]phenoxazine-5-one and benzo[α]phenoxazine-5-one.
Pal S; Salunke-Gawalib S; Konkimallaa VB
Anticancer Agents Med Chem; 2017; 17(1):115-125. PubMed ID: 27349450
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.
Sinn BV; Striefler JK; Rudl MA; Lehmann A; Bahra M; Denkert C; Sinn M; Stieler J; Klauschen F; Budczies J; Weichert W; Stenzinger A; Kamphues C; Dietel M; Riess H
Pancreas; 2014 May; 43(4):578-83. PubMed ID: 24681874
[TBL] [Abstract][Full Text] [Related]
14. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
15. Use of predictive markers in oncology: are phase 3 trials always required?
Markman M
Oncology; 2011; 81(1):1-2. PubMed ID: 21894048
[No Abstract] [Full Text] [Related]
16. K-ras mutations in the plasma correspond to computed tomographic findings in patients with pancreatic cancer.
Däbritz J; Preston R; Hänfler J; Oettle H
Pancreas; 2012 Mar; 41(2):323-5. PubMed ID: 22044911
[No Abstract] [Full Text] [Related]
17. Pancreatic cancer research matures.
Nelson NJ
J Natl Cancer Inst; 2007 Oct; 99(19):1432-4. PubMed ID: 17895469
[No Abstract] [Full Text] [Related]
18. Phenotype and genotype of pancreatic cancer cell lines.
Deer EL; González-Hernández J; Coursen JD; Shea JE; Ngatia J; Scaife CL; Firpo MA; Mulvihill SJ
Pancreas; 2010 May; 39(4):425-35. PubMed ID: 20418756
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
[TBL] [Abstract][Full Text] [Related]
20. Mouse Models of Pancreatic Ductal Adenocarcinoma.
Ponz-Sarvise M; Tuveson DA; Yu KH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):609-17. PubMed ID: 26226900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
